← Human Trials & Peer-Reviewed Studies
Leucine supplementation and serum amino acids, testosterone, cortisol and growth hormone in male power athletes during training.
Plain-language guide to PMID 9239992 (1997): double-blind randomized controlled trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
Key Facts
- PMID
- 9239992
- Journal
- The Journal of sports medicine and physical fitness
- Year
- 1997
- Study type
- Randomized Controlled Trial
- Authors
- Mero A et al. (6 authors)
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over), published as a randomized controlled trial.
The purpose of the present study was to examine the effects of leucine supplementation on the amino acid and hormone profile during training.
Who Took Part
PubMed indexes the participants as adults, men only.
Twenty adult male track and field power athletes finished the study.
How the Study Was Run
In design terms this was a randomized, double-blind, placebo-controlled and crossover study.
Random assignment meant chance, not the researchers, decided who got Exogenous HGH, sermorelin & older GHRPs (why they're passed over) and who got the comparison, which limits bias.
As a double-blind Exogenous HGH, sermorelin & older GHRPs (why they're passed over) study, the assignments were hidden from both participants and investigators until the end.
Some participants received a placebo instead of Exogenous HGH, sermorelin & older GHRPs (why they're passed over), giving a reference point.
In the crossover set-up each of the participants took both Exogenous HGH, sermorelin & older GHRPs (why they're passed over) and the comparison in turn, acting as their own control.
The study occurred during a sport training period.
What Was Measured
Topics PubMed links to this paper include Amino Acids, Food, Fortified, Growth Hormone, Hydrocortisone, Leucine, Testosterone and Track and Field.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
The abstract goes on to report its results in about 9 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 1997 (The Journal of sports medicine and physical fitness), a journal based in Italy.
More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.
Our Notes on the Compound
Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.